Medical - Devices
Compare Stocks
2 / 10Stock Comparison
VMD vs BRT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
VMD vs BRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | REIT - Residential |
| Market Cap | $353M | $277M |
| Revenue (TTM) | $287M | $98M |
| Net Income (TTM) | $15M | $-12M |
| Gross Margin | 57.5% | 12.6% |
| Operating Margin | 8.2% | 6.1% |
| Forward P/E | 19.2x | — |
| Total Debt | $16M | $508M |
| Cash & Equiv. | $14M | $25M |
VMD vs BRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Viemed Healthcare, … (VMD) | 100 | 110.6 | +10.6% |
| BRT Apartments Corp. (BRT) | 100 | 130.5 | +30.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VMD vs BRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.95
- Rev growth 20.5%, EPS growth 32.1%, 3Y rev CAGR 24.9%
- 413.5% 10Y total return vs BRT's 217.9%
BRT is the clearest fit if your priority is defensive.
- Beta 0.65, yield 7.1%, current ratio 0.86x
- Better valuation composite
- Beta 0.65 vs VMD's 0.95
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs BRT's 1.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.2% margin vs BRT's -12.5% | |
| Stability / Safety | Beta 0.65 vs VMD's 0.95 | |
| Dividends | 7.1% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +26.7% vs BRT's +2.7% | |
| Efficiency (ROA) | 7.5% ROA vs BRT's -1.7%, ROIC 11.6% vs 1.3% |
VMD vs BRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VMD vs BRT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
VMD leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
VMD is the larger business by revenue, generating $287M annually — 2.9x BRT's $98M. VMD is the more profitable business, keeping 5.2% of every revenue dollar as net income compared to BRT's -12.5%. On growth, VMD holds the edge at +27.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $287M | $98M |
| EBITDAEarnings before interest/tax | $46M | $33M |
| Net IncomeAfter-tax profit | $15M | -$12M |
| Free Cash FlowCash after capex | $26M | $16M |
| Gross MarginGross profit ÷ Revenue | +57.5% | +12.6% |
| Operating MarginEBIT ÷ Revenue | +8.2% | +6.1% |
| Net MarginNet income ÷ Revenue | +5.2% | -12.5% |
| FCF MarginFCF ÷ Revenue | +9.0% | +16.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.5% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -16.7% |
Valuation Metrics
BRT leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, VMD's 7.2x EV/EBITDA is more attractive than BRT's 20.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $353M | $277M |
| Enterprise ValueMkt cap + debt − cash | $356M | $760M |
| Trailing P/EPrice ÷ TTM EPS | 24.89x | -22.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.19x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 7.21x | 20.32x |
| Price / SalesMarket cap ÷ Revenue | 1.31x | 2.86x |
| Price / BookPrice ÷ Book value/share | 2.62x | 1.50x |
| Price / FCFMarket cap ÷ FCF | 29.59x | 25.60x |
Profitability & Efficiency
VMD leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
VMD delivers a 10.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-7 for BRT. VMD carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRT's 2.87x. On the Piotroski fundamental quality scale (0–9), VMD scores 4/9 vs BRT's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.5% | -6.8% |
| ROA (TTM)Return on assets | +7.5% | -1.7% |
| ROICReturn on invested capital | +11.6% | +1.3% |
| ROCEReturn on capital employed | +13.2% | +1.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.11x | 2.87x |
| Net DebtTotal debt minus cash | $2M | $483M |
| Cash & Equiv.Liquid assets | $14M | $25M |
| Total DebtShort + long-term debt | $16M | $508M |
| Interest CoverageEBIT ÷ Interest expense | 14.61x | 0.51x |
Total Returns (Dividends Reinvested)
Evenly matched — VMD and BRT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BRT five years ago would be worth $10,746 today (with dividends reinvested), compared to $9,624 for VMD. Over the past 12 months, VMD leads with a +26.7% total return vs BRT's +2.7%. The 3-year compound annual growth rate (CAGR) favors BRT at 0.3% vs VMD's -5.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +27.6% | +3.5% |
| 1-Year ReturnPast 12 months | +26.7% | +2.7% |
| 3-Year ReturnCumulative with dividends | -14.6% | +1.0% |
| 5-Year ReturnCumulative with dividends | -3.8% | +7.5% |
| 10-Year ReturnCumulative with dividends | +413.5% | +217.9% |
| CAGR (3Y)Annualised 3-year return | -5.1% | +0.3% |
Risk & Volatility
Evenly matched — VMD and BRT each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRT is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than VMD's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.65x |
| 52-Week HighHighest price in past year | $10.18 | $16.69 |
| 52-Week LowLowest price in past year | $5.93 | $13.18 |
| % of 52W HighCurrent price vs 52-week peak | +90.5% | +88.2% |
| RSI (14)Momentum oscillator 0–100 | 34.7 | 56.6 |
| Avg Volume (50D)Average daily shares traded | 312K | 54K |
Analyst Outlook
VMD leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates VMD as "Buy" and BRT as "Buy". BRT is the only dividend payer here at 7.13% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $21.00 |
| # AnalystsCovering analysts | 1 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% |
| Dividend StreakConsecutive years of raises | 2 | 0 |
| Dividend / ShareAnnual DPS | — | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +1.8% |
VMD leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BRT leads in 1 (Valuation Metrics). 2 tied.
VMD vs BRT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is VMD or BRT a better buy right now?
For growth investors, Viemed Healthcare, Inc.
(VMD) is the stronger pick with 20. 5% revenue growth year-over-year, versus 1. 5% for BRT Apartments Corp. (BRT). Viemed Healthcare, Inc. (VMD) offers the better valuation at 24. 9x trailing P/E (19. 2x forward), making it the more compelling value choice. Analysts rate Viemed Healthcare, Inc. (VMD) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — VMD or BRT?
Over the past 5 years, BRT Apartments Corp.
(BRT) delivered a total return of +7. 5%, compared to -3. 8% for Viemed Healthcare, Inc. (VMD). Over 10 years, the gap is even starker: VMD returned +413. 5% versus BRT's +217. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — VMD or BRT?
By beta (market sensitivity over 5 years), BRT Apartments Corp.
(BRT) is the lower-risk stock at 0. 65β versus Viemed Healthcare, Inc. 's 0. 95β — meaning VMD is approximately 45% more volatile than BRT relative to the S&P 500. On balance sheet safety, Viemed Healthcare, Inc. (VMD) carries a lower debt/equity ratio of 11% versus 3% for BRT Apartments Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — VMD or BRT?
By revenue growth (latest reported year), Viemed Healthcare, Inc.
(VMD) is pulling ahead at 20. 5% versus 1. 5% for BRT Apartments Corp. (BRT). On earnings-per-share growth, the picture is similar: Viemed Healthcare, Inc. grew EPS 32. 1% year-over-year, compared to -26. 9% for BRT Apartments Corp.. Over a 3-year CAGR, VMD leads at 24. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — VMD or BRT?
Viemed Healthcare, Inc.
(VMD) is the more profitable company, earning 5. 5% net margin versus -12. 3% for BRT Apartments Corp. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRT leads at 11. 4% versus 7. 7% for VMD. At the gross margin level — before operating expenses — VMD leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — VMD or BRT?
In this comparison, BRT (7.
1% yield) pays a dividend. VMD does not pay a meaningful dividend and should not be held primarily for income.
07Is VMD or BRT better for a retirement portfolio?
For long-horizon retirement investors, BRT Apartments Corp.
(BRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 65), 7. 1% yield, +217. 9% 10Y return). Both have compounded well over 10 years (BRT: +217. 9%, VMD: +413. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between VMD and BRT?
These companies operate in different sectors (VMD (Healthcare) and BRT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VMD is a small-cap high-growth stock; BRT is a small-cap income-oriented stock. BRT pays a dividend while VMD does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare BRT vs NHI
NHI is one of the most direct listed alternatives to BRT.
Compare VMD vs LINC
LINC overlaps with VMD in an adjacent operating segment worth comparing.
Expand With NHI + NXRT
NHI and NXRT are the strongest missing peers across the current compare set.